Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Human Health

Human HealthOur main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs.

Further reading »


Animal Health

Animal HealthAnimal Health develops and improves existing medical treatments focusing on oncology.

Further reading »


The Share

Latest News

Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing

July 7 2015
New York, July 7, 2015 -- Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, has filed a registration statement on Form F-1/A with the Securities and Exchange Commission, in connection with the proposed public offering of ordinary stock and listing on the NASDAQ Stock Market. The number of American Depositary Shares, representing ordinary shares, to be offered, and the price range for the offering have not yet been determined. An Investor Roadshow will be conducted in the US during July 2015.
Further reading »

Oasmia Pharmaceutical Launches US Brand and Sales Platform

July 7 2015
Company to build proprietary platform and sales network to introduce veterinarians to its leading companion animal therapeutic.
Further reading »

Year-end report for the fiscal year May 2014 – April 2015

June 4 2015
Paclical har fått marknadsgodkännande i Ryssland
Further reading »

bottom